Matthias Kroiss
Matthias Kroiss
University Hospital Würzburg
Verified email at
Cited by
Cited by
Combination chemotherapy in advanced adrenocortical carcinoma
M Fassnacht, M Terzolo, B Allolio, E Baudin, H Haak, A Berruti, S Welin, ...
New England Journal of Medicine 366 (23), 2189-2197, 2012
Integrated genomic characterization of adrenocortical carcinoma
G Assié, E Letouzé, M Fassnacht, A Jouinot, W Luscap, O Barreau, ...
Nature genetics 46 (6), 607-612, 2014
Comprehensive pan-genomic characterization of adrenocortical carcinoma
S Zheng, AD Cherniack, N Dewal, RA Moffitt, L Danilova, BA Murray, ...
Cancer cell 29 (5), 723-736, 2016
Adrenocortical carcinoma: a clinician's update
M Fassnacht, R Libé, M Kroiss, B Allolio
Nature Reviews Endocrinology 7 (6), 323-335, 2011
Update in adrenocortical carcinoma
M Fassnacht, M Kroiss, B Allolio
The Journal of Clinical Endocrinology & Metabolism 98 (12), 4551-4564, 2013
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers
LJ Wirth, E Sherman, B Robinson, B Solomon, H Kang, J Lorch, F Worden, ...
New England Journal of Medicine 383 (9), 825-835, 2020
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study
M Fassnacht, A Berruti, E Baudin, MJ Demeure, J Gilbert, H Haak, ...
The lancet oncology 16 (4), 426-435, 2015
Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection
F Beuschlein, J Weigel, W Saeger, M Kroiss, V Wild, F Daffara, R Libé, ...
The Journal of Clinical Endocrinology & Metabolism 100 (3), 841-849, 2015
Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study
R Libe, I Borget, CL Ronchi, B Zaggia, M Kroiss, T Kerkhofs, J Bertherat, ...
Annals of Oncology 26 (10), 2119-2125, 2015
Mitotane inhibits sterol-O-acyl transferase 1 triggering lipid-mediated endoplasmic reticulum stress and apoptosis in adrenocortical carcinoma cells
S Sbiera, E Leich, G Liebisch, I Sbiera, A Schirbel, L Wiemer, S Matysik, ...
Endocrinology 156 (11), 3895-3908, 2015
A copeptin-based approach in the diagnosis of diabetes insipidus
W Fenske, J Refardt, I Chifu, I Schnyder, B Winzeler, J Drummond, ...
New England Journal of Medicine 379 (5), 428-439, 2018
Sunitinib in refractory adrenocortical carcinoma: a phase II, single-arm, open-label trial
M Kroiss, M Quinkler, S Johanssen, NP van Erp, N Lankheet, A Pöllinger, ...
The Journal of Clinical Endocrinology & Metabolism 97 (10), 3495-3503, 2012
Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma
S Wortmann, M Quinkler, C Ritter, M Kroiss, S Johanssen, S Hahner, ...
European journal of endocrinology 162 (2), 349-356, 2010
The role of surgery in the management of recurrent adrenocortical carcinoma
I Erdogan, T Deutschbein, C Jurowich, M Kroiss, C Ronchi, M Quinkler, ...
The Journal of Clinical Endocrinology & Metabolism 98 (1), 181-191, 2013
Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection.
M Terzolo, E Baudin, A Ardito, M Kroiss, S Leboulleux, F Daffara, ...
Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma
M Kroiss, M Quinkler, WK Lutz, B Allolio, M Fassnacht
Clinical endocrinology 75 (5), 585-591, 2011
Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer
A Berruti, M Fassnacht, H Haak, T Else, E Baudin, P Sperone, M Kroiss, ...
European urology 65 (4), 832-838, 2014
Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatographytandem mass spectrometry: utility for diagnosis of dopamine …
M Peitzsch, A Prejbisz, M Kroiß, F Beuschlein, W Arlt, A Januszewicz, ...
Annals of Clinical Biochemistry 50 (2), 147-155, 2013
Mitotane monotherapy in patients with advanced adrenocortical carcinoma
F Megerle, W Herrmann, W Schloetelburg, CL Ronchi, A Pulzer, ...
The Journal of Clinical Endocrinology & Metabolism 103 (4), 1686-1695, 2018
Tdrd3 is a novel stress granule-associated protein interacting with the Fragile-X syndrome protein FMRP
B Linder, O Plöttner, M Kroiss, E Hartmann, B Laggerbauer, G Meister, ...
Human molecular genetics 17 (20), 3236-3246, 2008
The system can't perform the operation now. Try again later.
Articles 1–20